BUY MANGALAM DRUG AT 26, TARGET 45
REASON:
1. SALES UP TO 71%
2. NET PROFIT 10 CR. TURNAROUND
3. IPCA HOLD 11% EXPORT CANCER API
4. BIG GROWTH 20% CAGR,
5. FY16 EPS 8
REASON:
1. SALES UP TO 71%
2. NET PROFIT 10 CR. TURNAROUND
3. IPCA HOLD 11% EXPORT CANCER API
4. BIG GROWTH 20% CAGR,
5. FY16 EPS 8
No comments:
Post a Comment